中国生物制药（01177.HK）今日盘中大涨5.13%，表现强劲。该股的强势上涨与整体港股药品板块的普遍走强密切相关。
市场数据显示，港股药品股今日多数走强。除中国生物制药外，信达生物（01801.HK）涨幅接近15%，开拓药业（09939.HK）涨超7%，石药集团（01093.HK）涨幅超过5%。这表明投资者对医药行业整体保持乐观态度，推动了相关个股的集体上涨。
值得注意的是，中国生物制药昨日（6月3日）获得南向资金大幅增持，增持股数高达5174.39万股。这一举动显示出内地投资者对该公司未来发展前景的信心，可能是推动股价上涨的重要因素之一。截至昨日收盘，港股通共持有中国生物制药246918.79万股，占流通股的13.16%，显示出较高的机构持股比例。这种资金面的支持可能继续为该股股价提供上涨动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.